Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations

Imugene Gains Ethics Approval and Receives 5% Share Bump

By Mahlia Stewart, Monday, 09 January 2023

Imugene has now crossed ethics approval off is list, and the way is now clear for clinical trials to begin in Australia.

By Kiryll Prakapenka, Wednesday, 10 August 2022

Biotech immunotherapy company Imugene [ASX:IMU] rose more than 10% on Wednesday after releasing an update about its oncolytic virotherapy candidate.

By Izaac Ronay, Tuesday, 22 March 2022

In today’s Money Morning…the digital revolution…the next digital device…our worst decisions will be only a thought away…and more…

By Ryan Dinse, Monday, 07 February 2022

As the name suggests, an adoption curve is the process by which a new technology is taken up by the public at large.

By Ryan Clarkson-Ledward, Tuesday, 25 January 2022

Radio and communications manufacturer Codan [ASX:CDA] is defying the market today. The CDA Share price us up 17.92% at time of writing.

By Kiryll Prakapenka, Tuesday, 11 January 2022

PolyNovo [ASX:PNV] shares are rising today after the biotech stock reported its indicative half-year trading results.